Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.75% | 13.95% | 2.66% | 17.24% | 40.65% |
| Total Depreciation and Amortization | -3.86% | -11.23% | -5.47% | -4.44% | -3.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.79% | -12.44% | -3.65% | -31.08% | 19.12% |
| Change in Net Operating Assets | 1,240.22% | 74.26% | 62.30% | -396.66% | -104.41% |
| Cash from Operations | 59.12% | 30.64% | 35.87% | -107.00% | 18.06% |
| Capital Expenditure | -47.54% | -146.49% | -11.27% | 35.69% | -362.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,882.63% | 98.62% | -- | 778.07% | -95.59% |
| Cash from Investing | -8,695.13% | 95.13% | -109.75% | 979.11% | -98.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,139.65% | 18,505.00% | -3.54% | 260.56% | -94.66% |
| Repurchase of Common Stock | 33.29% | 21.19% | -129.04% | -3,818.85% | -160.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41,069.49% | -6,851.61% | 1,204.57% | -4,824.12% | 111.03% |
| Cash from Financing | 25,041.33% | 250.12% | -72.47% | -6,124.39% | -103.24% |
| Foreign Exchange rate Adjustments | 59.53% | -128.05% | 211.95% | 167.93% | -264.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -241.39% | 86.75% | 27.28% | 4,029.98% | -108.67% |